4-((5-BROMO-1H-INDOL-3-YL)METHYL)MORPHOLINE, 95.0%, 1g

(4S,6S)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride, 98%, 25g

Methyl 4-amino-1-methyl-1H-imidazole-2-carboxylate, 95.0%, 100mg

Cäsiumcarbonat 99,9 % 50 g

3-(4-Fluoro-phenylsulfanyl)-5-trifluoromethyl-pyridine-2-carbonitrile, 95.0%, 1g

1-(4-Nitrobenzyl)-1,2,4-triazole>98.0%(GC)5g

6,6-Dimethyl-5,7-dihydro-1H-indol-4-one, 95+%, 1g

GC-Kapillarsäule ROTI®Cap-5 MS, unpolar, L 15 m, Ø-Innen 0,25 mm, Filmd. 0,25 µm, 1 Stück

4-lodo-2-(methylthio)pyrimidine, 95.0%, 25g

(3-aminophenyl)(3,4-dimethylphenyl)methanone, 95.0%, 1g

Tiglic Acid>98.0%(GC)(T)500g

1-(3,4-Dichlorophenyl)-2,2,2-trifluoroethan-1-ol, 98%, 100mg

Boc-Tyr-OMe, 99.00%, 25g